Hosted on MSN
COVID-19 vaccine technology adapted to develop first mRNA defense against antibiotic-resistant bacteria
Researchers from Tel Aviv University and the Israel Institute for Biological Research in Ness Ziona have used the platform developed for COVID-19 vaccines to create the world's first mRNA-based ...
COVID-19 served as a major catalyst for the widespread adoption of remote patient monitoring, which helps to prevent hospitalizations, improve medication adherence, and enable early interventions by ...
The EMA approved Moderna's mRNA COVID-19 and flu vaccine, but US political battles and funding cuts threaten the future of mRNA vaccine innovation. Talha Burki reports.
The US Department of Health and Human Services said Thursday that it aims to accomplish within four years a scientific feat that hasn’t been achieved for the past 45: the development of a universal ...
The COVID-19 variant BA.3.2, nicknamed "Cicada," has been detected in at least 23 countries and half the states in the U.S. Studies offer insights into the health risks and burdens faced by people who ...
Health care workers wheel a Covid-19 patient through a hallway at the Southwestern Vermont Medical Center in Bennington on Dec. 13, 2021. Photo by Glenn Russell/VTDigger This is the first story in a ...
Science, technology and innovation will be at the heart of Africa’s recovery from the devastating coronavirus (COVID-19) pandemic and the continent’s ability to create sustainable jobs, Executive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results